@FierceMedDev: Add debt restructuring to Quest Diagnostics' numerous moves to improve things. Story | Follow @FierceMedDev
@MarkHFierce: Philips ventilator recall gets slapped with the FDA's Class I recall status--its most serious designation. More | Follow @MarkHFierce
@MichaelGFierce: NeuroDerm preps for Parkinson's patch PhII trial. Read in FierceDrugDelivery | Follow @MichaelGFierce
@EmilyWFierce: Roche gets glowing reviews from FDA panel for frontline HPV test. Article | Follow @EmilyWFierce
> Covidien ($COV) said it is launching a new mesh product designed for surgical laparoscopic and open ventral hernia repairs. News release
> Bacterin International is rolling out a new allograft implant designed for multilevel spine procedures and deformity patients. Item
> Surefire Medical gained both a 510(k) and CE mark for a new line of guiding catheters designed for radioembolization and chemoembolization procedures. News release
> Medtronic ($MDT) is looking for runners with medical device implants such as pacemakers, spinal or neurological devices to participate in a marathon coming up in October. Story
> Integra LifeSciences ($IART) won 510(k) clearance for titanium bone wedges used to repair foot bone fractures. Story
Biotech News
@FierceBiotech: Sage snags $38M from A-list VCs to bankroll its seizure drugs. More | Follow @FierceBiotech
@JohnCFierce: Circassia's record-busting $332M IPO inspires hopes of U.K. renaissance. News | Follow @JohnCFierce
@DamianFierce: Vectura bags respiratory biotech Activaero for $181M. Story | Follow @DamianFierce
@EmilyMFierce: Despite progress, tuberculosis persists in West European cities. Piece via Reuters | Follow @EmilyMFierce
> GlaxoSmithKline maps a route to regulators with positive PhIII asthma data. Article
> Tesaro pays $17M to team with AnaptysBio on cancer immunotherapies. More
Pharma News
@FiercePharma: Yesterday's top-read special report: The top 10 pharma companies by 2013 revenue. Read | Follow @FiercePharma
@TracyStaton: Uh-oh for Merck animal health: Hundreds more Zilmax-fed cattle died than Merck reported to FDA. Story via Reuters | Follow @TracyStaton
@EricPFierce: Sun Pharma plant joins FDA village of the banned. Story via FiercePharmaManufacturing | Follow @EricPFierce
@CarlyHFierce: Missed yesterday's issue of FiercePharmaMarketing? Got you covered | Follow @CarlyHFierce
> Pfizer's billion-dollar Celebrex patent loss has Mylan, Actavis revving up generics. Article
> High court dashes Actelion's hopes for $407M reprieve in Tracleer case. More
Pharma Manufacturing News
> CMO born from $2.6 billion merger comes on the scene as DPx. Story
> Sun Pharma plant joins the FDA list of banned Indian facilities. News
> FDA says Indian drugmaker made up data for API tests. Piece
> Bayer expands German plants as it preps for new hemophilia treatments. More
> Hikma hits the jackpot with doxycycline shortage. Coverage
> Pharma cargo theft takes new spike. Brief
Vaccines News
> Daiichi misses H5N1 vaccine production goal after low yields slash output. Story
> Analysts offer mixed reactions to Pfizer's Prevnar 13 data close-up. Article
> Northwest Bio, NewLink proceed with cancer vax trials to mixed reviews. News
> ImmusanT waits on early clinical data for its celiac disease vaccine. Story
> Study: Vaccinating diabetics against flu cuts risk of death by 28%. Article
> U.K. mulls adopting a 2-dose model for HPV vaccination. Brief
> Editor's Note: A story in Wednesday's issue of FierceMedicalDevices attributed some comments to a spokeswoman for PowerVision. The comments originated with the company's CEO, Barry Cheskin. A separate story on Hospira in the same edition was updated to more clearly state the compliance history of its Rocky Mount, NC, and Austin, TX, plants. Rocky Mount faced a previous warning letter but not the Austin operation.